Tempus AI wins FDA clearance for two AI-ECG tools
Tempus AI announced FDA clearance for two AI-powered ECG tools in October 2026, targeting undiagnosed heart conditions. The Tempus ECG-MR detects moderate or severe mitral regurgitation from standard 12-lead ECGs, while Tempus ECG-PH flags pulmonary hypertension with binary results. Both tools expand Tempus’s cardiovascular AI portfolio amid a market projected to grow from $2.01 billion in 2025…
Key points
- Tempus AI wins FDA clearance for two AI-ECG tools: Tempus ECG-MR and Tempus ECG-PH
- Market size for AI-ECG analysis grows from $2.01B in 2025 to $2.40B in 2026 at 19.3% CAGR
- Tempus stock down 17.7% year-over-year, trading at 7.3x forward P/S ratio
The clearances follow 510(k) approvals, a regulatory pathway for lower-risk medical devices. Tempus’s stock has fallen 17.7% over the past year, outpacing the industry’s 10.4% decline, and trades at a 7.3x forward P/S ratio, above the industry average of 4.82x. Competitors like GE Healthcare and iRhythm also advance AI-ECG tools, with iRhythm reporting 85% accuracy in pilot programs for arrhythmia detection.
Here's How Tempus AI is Capitalizing on AI-ECG Market Growth
finance.yahoo.com · 5 October 2026
Loading the full article…
This text was published by finance.yahoo.com and written by Sridatri Sarkar. It is reproduced here with attribution so you can read it in full; the rights remain with the publisher. Read it at the source ↗
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Enterprise & Industry
All →- HackerRank launches Chakra, an AI agent that conducts and scores job interviews · 1 src
- Satya Nadella asks if Microsoft can lead AI again · 3 src
- Microsoft camouflages 20+ data centers as nature while signing 20-year gas deal · 1 src
- Jacobs deploys digital twin at NVIDIA R&D facility under three-year SaaS deal · 1 src
- Everest Group says enterprise AI shifts from prediction to action · 1 src
Comments
via GitHub Discussions